Caxton Associates LLP boosted its holdings in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) by 152.5% in the 1st quarter, Holdings Channel reports. The fund owned 173,000 shares of the company’s stock after acquiring an additional 104,497 shares during the quarter. Caxton Associates LLP’s holdings in Azenta were worth $3,655,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of the business. Assetmark Inc. grew its position in shares of Azenta by 54.1% in the fourth quarter. Assetmark Inc. now owns 832 shares of the company’s stock valued at $28,000 after purchasing an additional 292 shares in the last quarter. Osaic Holdings Inc. lifted its position in Azenta by 44.9% during the second quarter. Osaic Holdings Inc. now owns 1,242 shares of the company’s stock worth $39,000 after buying an additional 385 shares in the last quarter. CWM LLC lifted its position in Azenta by 27.3% during the fourth quarter. CWM LLC now owns 1,822 shares of the company’s stock worth $61,000 after buying an additional 391 shares in the last quarter. Empowered Funds LLC boosted its stake in Azenta by 10.5% during the first quarter. Empowered Funds LLC now owns 6,482 shares of the company’s stock worth $225,000 after buying an additional 618 shares during the last quarter. Finally, Neuberger Berman Group LLC boosted its stake in Azenta by 8.9% during the fourth quarter. Neuberger Berman Group LLC now owns 8,379 shares of the company’s stock worth $279,000 after buying an additional 684 shares during the last quarter. 99.08% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Needham & Company LLC lowered their price target on shares of Azenta from $44.00 to $33.00 and set a “buy” rating on the stock in a research report on Wednesday, May 6th. Weiss Ratings raised shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 15th. Four analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $40.40.
Azenta Trading Up 4.2%
Shares of NASDAQ:AZTA opened at $28.30 on Friday. The company has a market capitalization of $1.30 billion, a price-to-earnings ratio of -7.15 and a beta of 1.37. Azenta, Inc. has a 12-month low of $15.93 and a 12-month high of $41.73. The business has a 50-day moving average price of $23.46 and a 200 day moving average price of $26.11.
Azenta (NASDAQ:AZTA – Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.16). The company had revenue of $144.79 million for the quarter, compared to analysts’ expectations of $148.47 million. Azenta had a positive return on equity of 1.23% and a negative net margin of 30.49%.The company’s quarterly revenue was up 1.4% compared to the same quarter last year. During the same period last year, the business earned $0.01 EPS.
About Azenta
Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.
In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.
Featured Stories
- Five stocks we like better than Azenta
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
